IL33 and allergic disease: Mouse models have extended our understanding of the requirements for IL-33 signaling in allergic diseases, showing that IL-33 expression increases in the lung during both the early and chronic phases of airborne allergen exposure, and that airway inflammation is significantly attenuated in Il1rl1-deficient mice27.